pamatolol

Known as: (2-(4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)phenyl) ethyl)carbamic acid methyl ester, methyl (4-(2-hydroxy-3-(isopropylamino)propoxy)phenylethyl)carbamate 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1978-2004
01219782004

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Prenalterol, previously characterized as a functionally cardioselective partial β-adrenoceptor agonist, was shown to relax K… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
1985
1985
The effects of atenolol (2–5 mmol/l), sotalol (1–2 mmol/l) and pamatolol (0.1–1 mmol/l), together with N-tertiary butyl… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1982
1982
Prenalterol, previously characterized as a functionally cardioselective partial beta-adrenoceptor agonist, was shown to relax K… (More)
Is this relevant?
1982
1982
Hamster adipocyte beta-adrenergic receptors were characterized by the effect on the lipolysis rate of several selective beta… (More)
Is this relevant?
1981
1981
The effects of a nonselective (isoproterenol), a beta-1 selective (prenalterol) and a beta-2-selective (procaterol) agonist on… (More)
Is this relevant?
1981
1981
The effects of various beta-adrenergic agents on insulin secretion were investigated in vivo in mice. The non-selective beta… (More)
Is this relevant?
1979
1979
Three beta-adrenoceptor antagonists--atenolol (A), metoprolol (M), and pamatolol (P)--were examined with respect to their effects… (More)
Is this relevant?
1979
1979
The systemic bioavailability, elimination half-life (t1/2), and plasma concentration--response relationships of pamatolol, a… (More)
Is this relevant?
1979
1979
The metabolism of pamatolol was studied in man, dogs, rats and mice after oral administration of a single dose. The drug was well… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1978
1978
A Phase I evaluation of a new adrenoceptor blocker, pamatolol, was performed in 10 healthy male volunteers. Minor reductions in… (More)
Is this relevant?